1AI — Algorae Pharmaceuticals Balance Sheet
0.000.00%
- AU$8.44m
- AU$6.03m
- AU$0.13m
Annual balance sheet for Algorae Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2.96 | 1.61 | 4.24 | 4.11 | 3.11 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.098 | 0.014 | 0.03 | 0.096 | 0.043 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3.07 | 1.63 | 4.27 | 4.21 | 3.19 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.276 | 0.016 | 0.005 | 0.005 | 0 |
Long Term Investments | |||||
Total Assets | 3.39 | 1.64 | 4.27 | 4.21 | 3.19 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.311 | 0.265 | 0.239 | 0.45 | 0.178 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.513 | 0.265 | 0.239 | 0.45 | 0.178 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 2.88 | 1.38 | 4.03 | 3.76 | 3.01 |
Total Liabilities & Shareholders' Equity | 3.39 | 1.64 | 4.27 | 4.21 | 3.19 |
Total Common Shares Outstanding |